Odontogenic myxoma
Odontogenic myxoma is a rare and benign odontogenic tumor that originates from the mesenchymal tissue of the tooth germ, specifically the dental papilla, dental follicle, or the periodontal ligament. It is characterized by its locally invasive and unencapsulated nature, which can lead to significant bone destruction if left untreated.
Epidemiology[edit | edit source]
Odontogenic myxomas are rare, accounting for approximately 3-6% of all odontogenic tumors. They are most commonly found in the second and third decades of life, with a slight predilection for females. The tumors are most commonly found in the mandible, particularly in the molar and premolar areas.
Clinical presentation[edit | edit source]
Patients with odontogenic myxoma often present with a painless swelling of the jaw. The tumor may cause displacement of teeth, and in some cases, it may be associated with an unerupted tooth. On radiographs, the tumor often presents as a multilocular radiolucent lesion with a "soap bubble" or "honeycomb" appearance.
Histopathology[edit | edit source]
Histologically, odontogenic myxomas are composed of stellate and spindle-shaped cells embedded within a myxoid extracellular matrix. The cells are often loosely arranged, and there is typically a lack of cellular atypia or mitotic figures. The tumor does not contain odontogenic epithelium, which distinguishes it from other odontogenic tumors.
Treatment[edit | edit source]
The treatment of choice for odontogenic myxoma is surgical excision. Due to the infiltrative nature of the tumor, a wide margin of normal tissue is often removed to prevent recurrence. In some cases, preoperative embolization may be performed to reduce blood loss during surgery. Following surgery, regular follow-up is necessary due to the high recurrence rate of the tumor.
Prognosis[edit | edit source]
The prognosis for patients with odontogenic myxoma is generally good, as the tumor is benign and does not metastasize. However, the tumor is locally aggressive and can cause significant bone destruction if not treated promptly. The recurrence rate is high, particularly if the tumor is not completely excised.
See also[edit | edit source]
Odontogenic myxoma Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD